Plasmology4
Plasmology4, with a valuation of $136.6 million, is raising funds on StartEngine. The company is developing a new treatment paradigm for multidrug-refractory wounds. Plasmology4 is developing a device called Plaz4 1000 based on the Plaz4 technology that aims to be a drug-free and painless solution for many potential indications. The company’s novel non-thermal plasma technology is patent-protected and aims to get FDA clearance by 2026. Robert Hummel founded Plasmology4 in February 2010. The current crowdfunding campaign has a minimum target of $14,999.40 and a maximum target of $1.23 million. The campaign proceeds will be used for research and development and working capital.
Investment Overview
Raised: $339,910
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 10/21/2024
- Close Date
- 01/20/2025
$14,999
$1,234,999
$500
Equity - Common
Seed
RegCF
$1.17
$136,593,401
Company & Team
Company
- Year Founded
- 2010
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $13,085,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 01/20/2025 | StartEngine | $136,593,401 | $339,910 | Equity - Common | Active | RegCF |